Context Capital Management’s Xynomic Pharmaceuticals Holdings, Inc. Warrant XYNPW Stock Holding History

Context Capital Management’s Portfolio XYNPW Stock Details XYNPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-63,000	Closed	-$5K	–	108
2019 Q3	$5K	Hold	63,000	–	–	﹤0.01%	89
2019 Q2	$13K	Buy	+63,000	New	+$12.3K	0.01%	85

Context Capital Management's XYNPW Position: Q4 2019 in Review

Context Capital Management sold out of Xynomic Pharmaceuticals Holdings, Inc. Warrant (XYNPW) in Q4 2019, closing a stake of 63,000 shares — an estimated $5K sold.

Context Capital Management first reported a position in XYNPW in Q2 2019 and held it in 2 quarters. The position peaked at $13K in Q2 2019. 0 funds tracked by Wall St. Rank hold XYNPW as of Q4 2019.

Context Capital Management reported no remaining Xynomic Pharmaceuticals Holdings, Inc. Warrant position as of Q4 2019 after selling out during the quarter.
Context Capital Management sold 63,000 Xynomic Pharmaceuticals Holdings, Inc. Warrant shares in Q4 2019, an estimated $5K.
Context Capital Management first reported a position in Xynomic Pharmaceuticals Holdings, Inc. Warrant in Q2 2019 and held it in 2 quarters.
Context Capital Management's Xynomic Pharmaceuticals Holdings, Inc. Warrant position peaked at $13K in Q2 2019.
0 funds tracked by Wall St. Rank held Xynomic Pharmaceuticals Holdings, Inc. Warrant as of Q4 2019.

Based on Context Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.